Related Experiment Video
Updated: Jan 29, 2026

A Method to Assess Bacteriocin Effects on the Gut Microbiota of Mice
Published on: July 25, 2017
Early-Life Gut Microbiota: Education of the Immune System and Links to Autoimmune Diseases
Pleun de Groen1,2, Samantha C Gouw3, Nordin M J Hanssen1,2
1Department of (Experimental) Vascular Medicine, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Insights
Early life gut microbiome development is crucial for immune maturation. Disruptions increase autoimmune disease risk, but microbiome restoration strategies haven't yet prevented disease onset.
Area of Science:
- Immunology
- Microbiology
- Pediatrics
Background:
- The early-life gut microbiome critically influences immune system development, including innate immunity, antigen presentation, and adaptive immune maturation.
- Disruptions like C-section, antibiotics, and formula feeding can deplete beneficial bacteria and impair functions like short-chain fatty acid (SCFA) production.
- These early-life dysbiosis patterns are linked to increased risks of pediatric autoimmune diseases such as type 1 diabetes and inflammatory bowel disease.
Purpose of the Study:
- To review current evidence on how the early-life gut microbiota impacts immune maturation and the development of autoimmune diseases.
- To focus on human studies investigating interventions aimed at restoring the early-life microbiome.
- To highlight the need for better understanding of the microbiome-immune axis for developing preventive strategies.
Main Methods:
- Systematic review of human observational and intervention studies.
- Analysis of studies involving probiotics, synbiotics, vaginal microbial transfer, and maternal fecal microbiota transplantation.
- Evaluation of reported outcomes related to microbiome restoration and autoimmune disease prevention.
Main Results:
- Interventions can partially restore gut microbiome composition and function in early life.
- No studies to date have reported the direct prevention of autoimmune disease development through early-life microbiome modulation.
- A gap exists in understanding the direct causal link between microbiome modulation and autoimmune disease prevention.
Conclusions:
- Targeting the early-life gut microbiome is a promising area for immune development research.
- Further research, particularly longitudinal studies evaluating autoimmune outcomes post-modulation, is essential.
- A deeper understanding of the early-life microbiome-immune axis is necessary to develop effective preventive strategies for autoimmune diseases.
Abstract:
Early life is a critical window for immune system development, during which the gut microbiome shapes innate immunity, antigen presentation, and adaptive immune maturation. Disruptions in microbial colonization-driven by factors such as cesarean delivery, antibiotic exposure, and formula feeding-deplete beneficial early-life taxa (e.g., Bifidobacterium, Bacteroides, and Enterococcus) and impair key microbial functions, including short-chain fatty acid (SCFA) production by these keystone species, alongside regulatory T cell induction. These dysbiosis patterns are associated with an increased risk of pediatric autoimmune diseases, notably type 1 diabetes, inflammatory bowel disease, celiac disease, and juvenile idiopathic arthritis. This review synthesizes current evidence on how the early-life microbiota influences immune maturation, with potential effects on the development of autoimmune diseases later in life. We specifically focus on human observational and intervention studies, where treatments with probiotics, synbiotics, vaginal microbial transfer, or maternal fecal microbiota transplantations have been shown to partially restore a disrupted microbiome. While restoration of the gut microbiome composition and function is the main reported outcome of these studies, to date, no reports have disclosed direct prevention of autoimmune disease development by targeting the early-life gut microbiome. In this regard, a better understanding of the early-life microbiome-immune axis is essential for developing targeted preventive strategies. Future research must prioritize longitudinal evaluation of autoimmune outcomes after microbiome modulation to reduce the burden of chronic immune-mediated diseases.
Related Concept Videos
Half-life of a Reaction
Characteristics of Life
What is the Immune System?
The Angiosperm Life Cycle
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
The Tree of Life - Bacteria, Archaea, Eukaryotes

